Upside:
– APOL +20% (reportedly in talks to buy Apollo Education Group in deal valued at ~$1B)
– BIOC +15% (announced in-network agreement with Blue Cross Blue Shield of Illinois)
– BURL +12% (narrowed Q4 guidance & affirmed FY15 EPS)
– SGI +11% (guidance)
– LULU +9% (guided Q4 higher)
– ACLS +8.4% (raised Q4 guidance)
– SAP +3.2% (prelim earnings)
– ROL +2.4% (positive broker commentary)
– BIG +2.4% (affirmed Q4 EPS; SSS +1-2%)
– ABMD +2.4% (prelim earnings)
– SNN +1.8% (acquired first-line cartilage repair product; terms not disclosed)
– PXD +1.5% (raised FY15 production growth guidance)
– AA +1.4% (earnings)
– AAL +1.2% (Affirmed Q4 PRASM)
– INTC +1.1% (positive broker commentary)
Downside:
– SKUL -20% (guidance)
– EGO -10% (CEO says look for more job cuts if Olympias does not get permits by end of Q1)
– GME -7.5% (reported 9wk to Jan 2nd Holiday SSS)